Delivery Order SPE2DX22D0010-SPE2D826FCH38
- Not listed
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fentanyl Transdermal Patch 37.5 micrograms, with a ceiling value of $1,934.74. The contract, awarded on July 25, 2025, employs firm fixed-price pricing and is scheduled for completion by July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,842.34 for Fentanyl Transdermal Patch 87.5mcg, with an ultimate completion date of December 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The pharmaceutical product will be delivered to the place of performance in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Fentanyl Transdermal Patch 37.5 mcg with a ceiling value of $8,748.75. This firm fixed-price delivery order, with an ultimate completion date of August 28, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through the federal...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $8,089.77 for fentanyl transdermal patches (37.5 mcg) under a firm fixed-price contract with the Defense Logistics Agency Medical Supply Chain. The award, issued on September 12, 2025, carries an ultimate completion date of September 15, 2025, and represents a non-competitive, non-set-aside procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order contract on January 5, 2026, valued at $3,031.46 for the supply of Fentanyl Transdermal Patch 37.5 mcg to support federal medical procurement needs. The contract is a firm fixed-price delivery order with an ultimate completion date of January 6, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made on a competitive, non-set-aside basis by the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fentanyl 37.5 mcg/hr patches in quantities of five units, valued at $1,118.52. This competitive award, made on October 21, 2025, with an ultimate completion date of October 22, 2025, utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will perform at its...
- The Defense Logistics Agency awarded a delivery order valued at $1,097.04 to AmerisourceBergen Drug Corp for the supply of Fentanyl 75 mcg/hr patches (quantity of 5 units). The contract is categorized as a firm fixed-price delivery order with an ultimate completion date of December 15, 2025, and carries no set-aside designation. This award was issued competitively and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.15 to AmerisourceBergen Drug Corp for the supply of Fentanyl 37.5 micrograms per hour patches (quantity 5) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order carries no set-aside designation and was awarded competitively. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This...
- The Defense Logistics Agency (DLA) awarded a $1,846.14 delivery order to AmerisourceBergen Drug Corp for Fentanyl 37.5 micrograms per hour transdermal patches (5-count units) on December 4, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order valued at $1,288.50 to AmerisourceBergen Drug Corp for Fentanyl 100 micrograms/2 milliliter transdermal patches on October 23, 2025, with an ultimate completion date of October 24, 2025. This non-set-aside, firm fixed-price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under AmerisourceBergen Drug Corp's larger...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCH38Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $8.77K delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Fentanyl Transdermal Patch 37.5mcg, with final delivery required by January 12, 2026. This is a firm fixed-price, non-competitive delivery order that leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order is issued under AmerisourceBergen's comprehensive global pharmaceutical support vehicle that enables the company to fulfill federal medical supply requirements worldwide in support of military healthcare programs. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), maintains an even larger IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, demonstrating the company's substantial role in the federal pharmaceutical supply chain. As a non-set-aside award, this order was awarded through full and open competition and reflects AmerisourceBergen's proven capability to meet government procurement requirements for controlled pharmaceutical substances and critical medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 1/8/26 |